Taysha Gene Therapies, Inc.
Status: Publicly traded
Direct answer
Taysha Gene Therapies, Inc. is publicly traded on NASDAQ under the ticker TSHA.
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome;...
Can you invest in Taysha Gene Therapies, Inc.?
Yes. Taysha Gene Therapies, Inc. is publicly traded on NASDAQ under the ticker TSHA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Taysha Gene Therapies, Inc.
Detailed equity research is provided by MarketSnap.